A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder (3)

Clinical trial NCT00658762 · TERMINATED

Trial details

NCT number: NCT00658762
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Generalized Anxiety Disorder

Start date: 2008-05-01
Primary completion: 2009-04-01
Enrollment: 286

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.